Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07129148 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mobile Health and Wearable Devices for Diabetes Complication Management

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 1, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Enrollment target: 1600 to 6000 · Site details revisedv2 Show 2 more changesShow less
    • Enrollment target: 1600 to 6000
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The value of intelligent lifestyle intervention for T2D and its complications has been initially explored, but evidence-based support for the effectiveness of related AI risk prediction models and intervention models remains to be confirmed. The primary objective of this study is to verify the effectiveness of an AI model for predicting the risk of T2D complications based on phenotype, laboratory indicators and wearable device indicators, and to explore the effect and applicability of an intelligent lifestyle intervention model combining wearable devices and smartphones in preventing T2D complications.
Trial Details
NCT Number NCT07129148
Lead Sponsor Second Xiangya Hospital of Central South University
Collaborators: First Hospital of China Medical University, The First Affiliated Hospital with Nanjing Medical University, First Affiliated Hospital of Harbin Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Kunming Medical University, Tianjin Medical University, Shanghai 6th People's Hospital, Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus, Sinocare
Conditions Diabetes Mellitus Type 2, Diabetes Mellitus Complications
Enrollment 6,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov